releases: https://www.enzi.senate.gov/public/index.cfm/news-releases?ContentRecord_id=47E292CB-0A91-4B52-BD31-84F456851F22
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.enzi.senate.gov/public/index.cfm/news-releases?ContentRecord_id=47E292CB-0A91-4B52-BD31-84F456851F22 | Senators question ethical safeguards of NIH policies liberalizing chimera creation | 2016-10-04 | 2016 | 2016-10 | Republican | House | WY | Michael Enzi | E000285 | www.enzi.senate.gov | legacy | Research involving animal and human cells isn’t just the stuff of science fiction and fantasy anymore. The National Institutes of Health (NIH) is proposing policies to make it easier to do research resulting in organisms that are both human and animal, often referred to as “chimeras.” While it is an area of study with the potential to provide a better understanding of human diseases, according to U.S. Senators Mike Enzi, R-Wyo., Pat Roberts, R-Kan., and Bill Cassidy, R-La., the research carries with it real world ethical questions. Last week the senators wrote a letter to NIH asking for more information about the proposal. “We support the agency’s mission to prevent diseases and conditions and find new treatments and cures but the NIH also has a responsibility to uphold the values of the Americans who fund its research,” the senators wrote. “American taxpayers’ money funds the NIH, and we are concerned by the prospect of those dollars advancing research that goes beyond the bounds of responsible and ethical research.” Chimera studies are experiments that introduce human stem cells into animal embryos. Currently, NIH is not funding any studies of that kind. In order to better understand the proposed changes and their effects from both an ethical and scientific perspective, the the letter requested more information on how the process would be administered and how serious ethical questions would be addressed. Click here for a copy of the letter. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |